A detailed history of Clarity Capital Partners LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clarity Capital Partners LLC holds 9,169 shares of EW stock, worth $645,314. This represents 0.36% of its overall portfolio holdings.

Number of Shares
9,169
Previous 7,857 16.7%
Holding current value
$645,314
Previous $726 Million 16.63%
% of portfolio
0.36%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$59.7 - $93.78 $78,326 - $123,039
1,312 Added 16.7%
9,169 $605 Million
Q2 2024

Jul 30, 2024

BUY
$84.3 - $94.31 $213,363 - $238,698
2,531 Added 47.52%
7,857 $726 Million
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $26,114 - $34,401
-360 Reduced 6.33%
5,326 $509 Million
Q4 2023

Feb 20, 2024

BUY
$61.71 - $77.76 $350,883 - $442,143
5,686 New
5,686 $434 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clarity Capital Partners LLC Portfolio

Follow Clarity Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarity Capital Partners LLC with notifications on news.